Calliditas Therapeutics Presents Data at the 61st European Renal Association Congress

Source :: PR Newswire. May 28, 2024
Publication Year :: 2024
Abstract: STOCKHOLM, May 28, 2024 /PRNewswire/ --Calliditas Therapeutics AB (Nasdaq: CALT) (Nasdaq Stockholm: CALTX)('Calliditas'), today announced the presentations of an additional efficacy analysis of Nefecon (TARPEYO(budesonide) delayed release capsules)) as well [...]

Subjects :: Corticosteroids -- Analysis
Immunoglobulin A -- Analysis
Kidney diseases -- Development and progression
Business
News, opinion and commentary
Tarpeyo (Medication)

Tools